Transgenic ungulates capable of human antibody production
Details for Australian Patent Application No. 2003245300 (hide)
International Classifications
Event Publications
25 September 2003 Complete Application Filed
Priority application(s): 60/381,531 17.05.02 US; 60/425,056 08.11.02 US
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003245300
3 May 2007 Assignment before Grant
Hematech, LLC; Kirin Beer Kabushiki Kaisha The application has been assigned to Kirin Beer Kabushiki Kaisha
27 September 2007 Application Accepted
Published as AU-B-2003245300
24 January 2008 Standard Patent Sealed
10 July 2008 Alteration of Name
The name of the patentee has been altered to Kirin Holdings Kabushiki Kaisha
9 October 2008 Assignment Registered
Kirin Holdings Kabushiki Kaisha The patent has been assigned to Kirin Pharma Kabushiki Kaisha
19 March 2009 Assignment Registered
Kirin Pharma Kabushiki Kaisha The patent has been assigned to Kyowa Hakko Kirin Co., Ltd.
17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003245299-LACTAM GLYCOGEN PHOSPHORYLASE INHIBITORS AND METHOD OF USE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser